Report updated Jun 1, 2026
Mosby’s Nursing Drug Reference
For nursing students and practicing clinicians requiring rapid, evidence-based drug information and safety alerts during clinical rotations.
Mosby’s Nursing Drug Reference is an established medical app that is available. With a 4.0/5 rating from 262 reviews, it shows polarized user reception.
What is Mosby’s Nursing Drug Reference?
Mosby’s Nursing Drug Reference is a clinical pharmacology tool for nursing students and clinicians, providing drug monographs and medical calculators on iOS and Android.
Users hire this app to minimize medication dispensing errors through verified safety alerts, replacing the need for bulky printed handbooks during clinical rotations.
Current Momentum
v5.8
- Added 35 FDA-approved drug monographs.
- Improved memory management for launch speeds.
Active Nemesis
Nursing Central
By Unbound Medicine
Other Rivals
7-Day Rank Pulse 🇺🇸
MedicalNo ranking data
Rating Pulse 🇺🇸
What makes this app unique?
What Does It Look Like?
Loading...
What Are The Key Features?
Access to 5,000+ generic and trade name drug profiles including FDA-approved entries
Visual indicators for critical interactions and side effects within drug monographs
26 specialized medical calculators for clinical decision support
How much does it cost?
- Free app with sample content
- Yearly auto-renewing subscription at $44.99 for full content access
Subscription model anchored at $44.99/year, gating full clinical database access behind an annual recurring payment.
Who Built It?
Skyscape Medpresso
Providing healthcare professionals with mobile-first clinical decision support and secure communication tools. Enabling evidence-based care at the point of decision.
Portfolio
13
Apps
What other apps does Skyscape Medpresso make?
Saunders Comp Review NCLEX RN
Nursing Constellation Plus+
Essential Guide to Acute Care
Emergency Medicine On Call
Swanton's Cardiology
Handbook Clinical Anesthesia
Explore the full Skyscape Medpresso report
Portfolio breakdown, audience, momentum, and every app published by Skyscape Medpresso.
What do users think recently?
Analysis in progress, available soon
View the full user-sentiment analysis
Mood gauge, ratings & review-volume history, every praise / complaint / request, and sentiment over time.
What is the competitive landscape for Mosby’s Nursing Drug Reference?
How's The Medical Market?
How does it evolve in the Medical market?
The app maintains a #80 Grossing rank in the US Medical category, but the 3.4-star rating on Android indicates significant friction compared to the iOS experience. This performance gap suggests that technical instability on Android is actively eroding the app's professional credibility.
Rank progression
75 active rankings tracked — 30-day window
Which niche is Mosby’s Nursing Drug Reference in?
to access clinical drug safety information
Explore the full Pharmacology Guides niche
Every app in this space — 6 tracked, the niche's live rankings, and Marlvel's editorial take on the job-to-be-done.
The rivals identified
Nemeses(1)
This is the most direct competitor, offering a comprehensive nursing-specific drug reference suite that mirrors the target's core value proposition.
Differentiators
- Integrates multiple nursing-specific databases beyond just drug references into a single unified clinical workflow tool.
- Provides cross-linked access to disease, test, and procedure information which the target app currently lacks.
- Maintains a consistent, high-frequency update cycle for clinical content that builds long-term professional trust.
Head to head
The target must pivot from a standalone drug reference to a broader clinical decision support tool to prevent user migration to Nursing Central's all-in-one ecosystem.
Contenders(2)
A massive, multi-disciplinary medical platform that captures the broader professional audience the target app serves.
Differentiators
- Provides a massive, free, and constantly updated drug database that makes paid standalone references harder to justify.
- Includes clinical news, CME credits, and professional networking features that create a powerful daily-use habit.
A direct thematic competitor specifically targeting the nursing drug reference market with high user satisfaction.
Differentiators
- Features a highly specialized nursing-focused drug guide that directly competes with Mosby's core content.
- Optimized for quick-reference lookup during clinical shifts, prioritizing speed over the target's broader feature set.
Same space(3)
Focuses on the clinical calculation utility that is a secondary feature of the target app.
Differentiators
- Specializes in highly specific clinical decision rules and calculators that outperform general-purpose drug reference app tools.
- Provides a streamlined, utility-first interface that minimizes the time required to reach a clinical calculation result.
Dominates the professional networking and clinical communication space, capturing significant time from the target's user base.
Differentiators
- Facilitates secure clinical communication and telehealth, shifting the app's utility from reference to active clinical workflow.
- Leverages a massive professional network to drive engagement through career, news, and peer-to-peer connection features.
The gold standard for clinical decision support, serving as the ultimate reference for the target's professional audience.
Differentiators
- Offers evidence-based clinical content that is widely considered the industry standard for physician and nurse decision-making.
- Operates on a high-value institutional subscription model that creates significant barriers to entry for smaller apps.
New entrants(1)
Captures the student segment of the nursing market with high-frequency updates and exam-focused content.
Differentiators
- Utilizes gamified learning and adaptive testing modules to increase student engagement during the exam preparation phase.
- Provides detailed performance analytics that help students identify knowledge gaps, a feature absent in static drug references.
Compare Mosby’s Nursing Drug Reference against every rival
All rivals in one side-by-side table — identity, store metrics, ratings & sentiment, and strategic intel — plus a head-to-head page for each.
The outtake for Mosby’s Nursing Drug Reference
Strengths to defend, gaps to attack
Core Strengths
- Safety Alert icons function as a clinical trust moat
- Nursing Process framework aligns with academic curriculum requirements
Critical Frictions
- $44.99/year subscription price exceeds free-tier utility of Medscape
- 3.4 rating on Android suggests stability issues
Growth Levers
- Integration of wearable-based clinical alerts
- B2B partnerships with nursing schools for bulk license distribution
Market Threats
- UpToDate’s institutional dominance limits professional growth
- Medscape’s free, multi-disciplinary model drains the casual-user funnel
What are the next best moves?
Rebuild Android core to match iOS stability because the 3.4 rating indicates technical churn → recover Android user base
Android rating is significantly lower than iOS, creating a barrier to professional adoption.
Trade-off: Pause the Evolve-only monograph expansion — stability is a higher churn risk than content volume.
Audit the $44.99 annual price point against Medscape's free model because conversion data suggests price sensitivity → reduce abandonment
Medscape's free, multi-disciplinary model makes paid standalone references harder to justify.
Trade-off: Defer the new clinical calculator development — pricing alignment is more critical for long-term retention.
A counter-intuitive read
The app's lack of broader diagnostic content is a feature, not a bug, as it allows for a faster, distraction-free lookup workflow that bloated all-in-one clinical tools cannot match.
Feature Gaps vs Competitors
- Cross-linked disease and diagnostic references (available in Nursing Central but absent here)
- Professional networking and clinical communication features (available in Doximity but absent here)
Key Takeaways
The app maintains clinical authority through specialized safety alerts, but the high $44.99 price point and Android technical instability invite migration to free alternatives, so the PM must prioritize platform parity to defend the existing user base.
Where Is It Heading?
Mixed Signals
The medical reference market is consolidating around free, multi-disciplinary platforms that offer broader utility than standalone drug guides. Mosby's must transition from a static reference tool to a workflow-integrated clinical assistant to prevent further user migration to all-in-one competitors.
Android technical instability (3.4 rating) creates a barrier to professional adoption, which compounds the churn risk against free competitors.
The addition of 35 FDA-approved monographs demonstrates active clinical content maintenance, which sustains the app's value for current subscribers.